Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report-Reference-Cited by-同舟云学术

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report

Published:2019-01-25 Issue: Volume:24 Page:52-56
ISSN:2329-0358
Container-title:Annals of Transplantation
language:en
Short-container-title:Ann Transplant

Author:

Bösmüller Claudia¹,Messner Franka¹,Margreiter Christian¹,Öllinger Robert²,Maglione Manuel¹,Oberhuber Rupert¹,Scheidl Stefan¹,Neuwirt Hannes³,Öfner Dietmar¹,Margreiter Raimund¹,Schneeberger Stefan¹

Affiliation:

1. Department of Transplant Surgery, Medical University of Innsbruck, Innsbruck, Austria

2. Department of General Surgery, Charité Virchow Hospital Berlin, Berlin, Germany

3. Department of Internal Medicine IV (Nephrology and Hypertension), Medical University of Innsbruck, Innsbruck, Austria

Publisher

International Scientific Information, Inc.

Subject

Transplantation,General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive update of the metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation;Expert Opinion on Drug Metabolism & Toxicology;2023-07-03

2. Induction Therapy;Transplantation of the Pancreas;2023

3. Initial Transplant Hospitalization;Transplantation of the Pancreas;2023

4. A Network Meta-Analysis of Induction Immunosuppression for Simultaneous Pancreas-Kidney Transplant From Randomized Clinical Trials;Experimental and Clinical Transplantation;2021-05

5. Working towards an ERAS Protocol for Pancreatic Transplantation: A Narrative Review;Journal of Clinical Medicine;2021-04-01